Is mitral regurgitation a viable treatment target in heart failure? The plot just thickened

Journal of the American College of Cardiology

Volumn 45, Issue 3, 2005, Pages 388-390

  Mehra, Mandeep R ^a,c   Griffith, Bartley P ^b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANNULOPLASTY; ARTICLE; CLINICAL OBSERVATION; DEVICE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART STROKE VOLUME; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; MEDICAL ASSESSMENT; MEDICAL INFORMATION; MITRAL VALVE REGURGITATION; MORTALITY; PATHOLOGICAL ANATOMY; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SURGEON; SURGICAL APPROACH; SURGICAL PATIENT; SURGICAL TECHNIQUE; SURVIVAL TIME; SYMPTOM; TREATMENT OUTCOME;

EID: 13244260933     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.11.007     Document Type: Editorial

References (28)

1. M.A. Romano, S.F. Bolling Mitral valve repair as an alternative treatment for heart failure patients Heart Fail Monit 4 2003 7 12
2. E.S. Bishay, P.M. McCarthy, D.M. Cosgrove Mitral valve surgery in patients with severe left ventricular dysfunction Eur J Cardiothorac Surg 17 2000 213 221
3. J.D. Robbins, P.B. Maniar, W. Cotts, M.A. Parker, R.O. Bonow, M. Gheorghiade Prevalence and severity of mitral regurgitation in chronic systolic heart failure Am J Cardiol 91 2003 360 362
4. B.H. Trichon, G.M. Felker, L.K. Shaw, C.H. Cabell, C.M. O'Connor Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure Am J Cardiol 91 2003 538 543
5. T.M. Koelling, K.D. Aaronson, R.J. Cody, D.S. Bach, W.F. Armstrong Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction Am Heart J 144 2002 524 529
6. F.Y. Chen, L.H. Cohn The surgical treatment of heart failure A new frontier: nontransplant surgical alternatives in heart failure Cardiol Rev 10 2002 326 333
7. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-7.
8. M.M. Joffe, P.R. Rosenbaum Invited commentary: propensity scores Am J Epidemiol 150 1999 327 333
9. D.O. Taylor, L.B. Edwards, P.J. Mohacsi The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report--2003 J Heart Lung Transplant 22 2003 616 624
10. S.E. Karagiannis, G.T. Karatasakis, N. Koutsogiannis, G.D. Athanasopoulos, D.V. Cokkinos Increased distance between mitral valve coaptation point and mitral annular plane: significance and correlations in patients with heart failure Heart 89 2003 1174 1178
11. S.L. Nielsen, H. Nygaard, L. Mandrup Mechanism of incomplete mitral leaflet coaptation--interaction of chordal restraint and changes in mitral leaflet coaptation geometry Insight from in vitro validation of the premise of force equilibrium J Biomech Eng 124 2002 596 608
12. S.A. Tahta, J.H. Oury, J.M. Maxwell, S.P. Hiro, C.M. Duran Outcome after mitral valve repair for functional ischemic mitral regurgitation J Heart Valve Disease 11 2002 11 18
13. M.R. Mehra, P.A. Uber, G.S. Francis Heart failure therapy at a crossroad: are there limits to the neurohormonal model? J Am Coll Cardiol 41 2003 1606 1610
14. S. Nemoto, M. Hamawaki, G. De Freitas, B.A. Carabello Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation J Am Coll Cardiol 40 2002 149 154
15. S. Capomolla, O. Febo, M. Gnemmi Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol Am Heart J 139 2000 596 608
16. B.D. Lowes, E.A. Gill, W.T. Abraham Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure Am J Cardiol 83 1999 1201 1205
17. L.B. Rosario, L.W. Stevenson, S.D. Solomon, R.T. Lee, S.C. Reimold The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size J Am Coll Cardiol 32 1998 1819 1824
18. M.R. Mehra, B.H. Greenberg Cardiac resynchronization therapy: caveat medicus! J Am Coll Cardiol 3 2004 1145 1148
19. O.A. Breithardt, A.M. Sinha, E. Schwammenthal Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure J Am Coll Cardiol 41 2003 765 770
20. M.G. St. John Sutton, T. Plappert, W.T. Abraham, A.L. Smith, D.B. DeLurgio, A.R. Leon., for the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure Circulation 107 2003 1985 1990
21. A. Matsunaga, S.A. Tahta, C.M. Duran Failure of reduction annuloplasty for functional ischemic mitral regurgitation J Heart Valve Dis 13 2004 390 397 ; discussion 397-8
22. L. Menicanti, M. DiDonato, A. Frigiola., for the RESTORE Group Ischemic mitral regurgitation: Intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration J Thorac Cardiovasc Surg 123 2002 1041 1050
23. I.L. Kron, G.R. Green, J.T. Cope Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation Ann Thorac Surg 74 2002 600 601
24. E. Messas, B. Poiuzet, B. Touchot Efficacy of chordal cutting to relieve chronic persistent ischemic MR Circulation 108 2003 II11 5
25. S.L. Moainie, T.S. Guy, J.H. Gorman III Infarct restraint attenuates remodeling and reduces chronic ischemic mitral regurgitation after posterolateral infarction Ann Thorac Surg 74 2002 444 449
26. D.L. Mann, M.A. Acker, M. Jessup, H.N. Sabbah, R.C. Starling, S.H. Kubo ACORN Investigators and Study Coordinators Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure J Card Fail 10 2004 185 192
27. D.M. Kaye, M. Byrne, C. Alferness, J. Power Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation Circulation 108 2003 1795 1797
28. Liddicoat JR, MacNeill BD, Gillinov AM, et al. Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv 200360:410-416.